Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

Abgenix reports positive preclinical results for ABX-IL-8

Sep. 15, 1999

Hair growth promoters developed at Shiseido

Sep. 13, 1999

Access initiates clinical trial of OraDisc for amlexanox delivery

Sep. 10, 1999

Fujisawa seeks approval for tacrolimus ointment in the U.S.

Sep. 10, 1999

Vitrix soon to enter expanded clinical development

Sep. 10, 1999

Licensing opportunity from NIH: thymosin beta4 as a wound-healing agent

Sep. 7, 1999

Genzyme Tissue Repair's TGF-beta2 sponge evaluated in phase II diabetic foot ulcers

Sep. 3, 1999

ACS news: new compounds from Merck & Co. potently and selectively inhibit 5alpha-reductase type 1

Sep. 1, 1999

AGN-194310, a high-affinity RAR antagonist for treating retinoid-induced toxicities

Sep. 1, 1999

Apligraf skin construct speeds healing of diabetic foot ulcers

Aug. 31, 1999

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...